Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC1102 (Lenvervimab) in HBV-related Liver Transplant
NCT02304315Phase 2Completed
- Sponsor
- GC Biopharma
- Start
- Feb 2015
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of GC5103 in hepatitis B (HBV), sponsored by GC Biopharma. Started Feb 2015; status: completed.
02
Drugs
GC5103
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02304315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304315.